antigen-about-main

Management Team

xiaowu-liang

Xiaowu Liang, Ph.D. Co-founder, Chairman & CEO

Ph.D. in molecular biology from UC San Diego/Salk Institute and Postdoctoral at UC Berkeley. Executive training in Leadership and Strategy in Pharmaceuticals and Biotech, Harvard Business School. Lead Scientist of Bio-defense Division at Life Technologies Corporation. Senior research position at Vical, Inc.

angela-yee

Angela Yee Co-founder, Board Member, COO & CFO

B.S. degree in Business Administration and Finance from the University of California, Riverside. Management at CoreValve, Inc., a “start-up” medical device company acquired by Medtronic, Inc. Financial management positions including VP of Finance at CETI and NTD technologies. Corporate Controller at Thuris Corporation, a medical device and pharmaceutical company.

joe-campo

Joe Campo, Ph.D. Director of Operations

Ph.D. in Medicine from University of Barcelona & M.Sc. in Control of Infectious Diseases from London School of Hygiene & Tropical Medicine. Leadership roles in coordinating African laboratory and field teams for clinical trials at the Barcelona Center for Global Health Research. Preclinical and clinical vaccine development at Naval Medical Research Center.

gary-hermanson

Gary Hermanson, Ph.D. Director of Product Development

Ph.D. in Molecular Biology at UC, Los Angeles and Postdoctoral at the Salk Institute. Leadership roles in molecular biology, fermentation, GMP manufacturing, regulatory affairs, and vaccine development projects at Vical, Inc. Senior research and leadership roles at Epimmune and Cytel.

arlo-randall

Arlo Randall, Ph.D. Director of Bioinformatics

Ph.D. in Information and Computer Science from UC, Irvine. Leadership roles in interdisciplinary research projects at the UCI Institute for Genomics and Bioinformatics. Bioinformatics Scientist at Applied Proteomics, Inc. Extensive experience in experimental design and biomarker discovery utilizing mass spectrometry and protein microarray data.